Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
DDX3 (L318) Peptide BS1629P
Product NameDDX3 (L318) Peptide
Catalog No.BS1629P
ApplicationsBlocking
Swiss-ProtO00571
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide DDX3 (L318). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS1629 DDX3 (L318) pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
DDX3 (L318) Peptide
Applications :
Blocking
Background :
DDX3 contains all of the motifs of the DEAD box family of RNA helicases, including the Asp/Glu/Ala/Asp sequence that gives the protein family its name and distinguishes it from other RNA helicases. DDX3 is localized to the X chromosome and has a highly conserved functional homolog (DBY) on the Y chromosome. DDX3 is thought to be involved in RNA splicing, RNA transport, and translation initiation. It is also involved in cell growth control and is deregulated in hepatitis virus associated hepatocellular carcinoma. Recent experiments suppressing DDX3 expression blocked HIV1 RNA export from the nucleus, suggesting that DDX3 functions as a shuttling protein that transports the HIV1 protein Rev and its cofactor CRM1 from the nucleus to the cytoplasm.
Alternative Name :
ATP-dependent RNA helicase DDX3X; DEAD box protein 3, X-chromosomal; DEAD box, X isoform; Helicase-like protein 2; HLP2; DDX3X; DBX; DDX3
Swiss-Prot :
O00571
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide DDX3 (L318). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS1629 DDX3 (L318) pAb.
Blocking peptide available as BS1629PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER